Data Update: Faricimab for AMD & DME

Carl D. Regillo, MD

Show Description +

Dr. Regillo provides a look at 2-year data for this therapy, further supporting its FDA approval.

Posted: 3/25/2022

Keywords:

Age-Related Macular Degeneration (AMD)

•

DME

•

Faricimab

•

retina-meeting-recap

Up Next

Name: Data Update: Faricimab for AMD & DME
Uploaded: 2022-03-25T16:48:57+00:00
Description: Dr. Regillo provides a look at 2-year data for this therapy, further supporting its FDA approval.

The Promise of Dry AMD Therapies

Joan W. Miller, MD

PDS Implantation Tips and Tricks

Carl C. Awh, MD, FASRS

Gene Therapy for IRDs: The How and Why of Imaging

Aleksandra Rachitskaya, MD; and Timothy G. Murray, MD, MBA

Advances in Diabetic Eye Disease Management

Judy E. Kim, MD; and Timothy G. Murray, MD, MBA

Clinical Insights from High-Resolution OCT

K. Bailey Freund, MD; Timothy Murray, MD

Complex RD? Consider Medium-Term PFO

Steve Charles, MD, FACS, FICS

Three Decades of Surgical Training

H. Culver Boldt, MD

Advances in Ocular Oncology

Timothy G. Murray, MD, MBA

Back to All Videos

Data Update: Faricimab for AMD & DME

Carl D. Regillo, MD

Dr. Regillo provides a look at 2-year data for this therapy, further supporting its FDA approval.

Posted: 3/25/2022

Keywords:

Age-Related Macular Degeneration (AMD)

•

DME

•

Faricimab

•

retina-meeting-recap

Please log in to leave a comment.

More From ARDS: 2022 Coverage

Gene Therapy for IRDs: The How and Why of Imaging

Aleksandra Rachitskaya, MD; and Timothy G. Murray, MD, MBA

Advances in Diabetic Eye Disease Management

Judy E. Kim, MD; and Timothy G. Murray, MD, MBA

Clinical Insights from High-Resolution OCT

K. Bailey Freund, MD; Timothy Murray, MD

Complex RD? Consider Medium-Term PFO

Steve Charles, MD, FACS, FICS

Meeting Coverage:

Aspen Retinal Detachment Society

Data Update: Faricimab for AMD & DME

Up Next

Data Update: Faricimab for AMD & DME

More From ARDS: 2022 Coverage